Phase II study of vitamin B12 and folate supplementation for patients undergoing cisplatin plus pemetrexed therapy.

Not Applicable

• Conditions: on small-cell lung cancer

• Registration Number: JPRN-UMIN000006546
• Lead Sponsor: Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-10-14
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1. Extensive interstitial pneumonitis 2. Severe complications 3. Active infection 4. History of cytotoxic chemotherapy 5. Active coexistent cancer 6. Need for continuous and systemic administration of corticosteroids 7. Need for continuous and systemic administration of vitamin B12 8. Symptomatic brain metastases 9. Massive pleural effusion or ascites 10. History of irradiation to more than half of pelvic bone 11. Allergy to treatment drugs 12. Pregnant or breast-feeding 13. Unable to take drugs orally 14. Other conditions inadequate for this research

Study & Design

• Study Type: Interventional
• Study Design: Not specified